Home » Newsletters » BioWorld Science

BioWorld Science

June 13, 2006

View Archived Issues

Protherics to acquire CoVaccine's novel adjuvant for angiotensin vaccine

Development & manufacturing agreement for A&G anti-GP88 cancer therapeutic antibody

MorphoSys and OncoMed sign HuCAL agreement for cancer research

NOMAC/E2 combined oral contraceptive enters phase III

SPARC study of satraplatin cleared to continue to completion

HuMax-CD38 blocks ectoenzymatic activity of CD38 in preclinical studies

Criterion reached for interim efficacy statistical analysis of PRECISE study

ProLindac studied in phase II trial for ovarian cancer

AstraZeneca updates status of development portfolio

Phase II data on GVAX cancer immunotherapy in CML reported

Phase I data on BIBF-1120 for advanced solid tumors

DN-101 shows activity in NSCLC study

Pharming's acquisition of DNage delayed by appeal

MORAb-003 begins phase II studies

MRX-5 improves IBD symptoms in preclinical studies

Neumune cleared for clinical study in patients at risk of nosocomial infections

Medicine status for Mologen's cell-based gene therapy for kidney cancer

Orphan drug designation for ropidoxuridine in malignant glioma

U.K.'s NICE recommends use of Herceptin

BioDelivery Sciences discusses Emezine path forward with FDA

Novel therapeutic agents for respiratory disorders disclosed in recent patents

Novel agents for urological disorders disclosed in recent patent literature

Recent patents report novel analgesic agents

Encouraging early clinical data reported on SGN-40 in Atlanta

Elacyt safety improved on new administration schedule tested in patients with solid tumors

Initial results of phase I trial of Patrin and dacarbazine in patients with solid tumors

MDX-214, a novel immunotherapeutic strategy for EGFR+ tumors

Axitinib demonstrates promising activity in pancreatic and thyroid cancer

DPP-IV inhibitor developed at Point Therapeutics shows antidiabetic potential in preclinical studies

New vitamin D receptor modulators show efficacy in a preclinical model of psoriasis

Folate-mitomycin conjugates suppress tumor growth in combination with paclitaxel